Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Intangibles (2016 - 2025)

Historic Intangibles for Fortress Biotech (FBIO) over the last 11 years, with Q3 2025 value amounting to $28.7 million.

  • Fortress Biotech's Intangibles rose 6067.03% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 6067.03%. This contributed to the annual value of $31.9 million for FY2024, which is 5706.12% up from last year.
  • Per Fortress Biotech's latest filing, its Intangibles stood at $28.7 million for Q3 2025, which was up 6067.03% from $29.7 million recorded in Q2 2025.
  • Fortress Biotech's Intangibles' 5-year high stood at $31.9 million during Q4 2024, with a 5-year trough of $12.6 million in Q4 2021.
  • For the 5-year period, Fortress Biotech's Intangibles averaged around $23.8 million, with its median value being $21.9 million (2023).
  • Data for Fortress Biotech's Intangibles shows a peak YoY increase of 18503.07% (in 2021) and a maximum YoY decrease of 3253.79% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Fortress Biotech's Intangibles stood at $12.6 million in 2021, then surged by 116.67% to $27.2 million in 2022, then fell by 25.41% to $20.3 million in 2023, then soared by 57.06% to $31.9 million in 2024, then dropped by 10.02% to $28.7 million in 2025.
  • Its last three reported values are $28.7 million in Q3 2025, $29.7 million for Q2 2025, and $30.8 million during Q1 2025.